新聞HDT Bio partnered with McGill University on Jul 12th '26.HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in Canada MONTREAL and SEATTLE, July 12, 2026 /PRNewswire/ - Among the deadliest of brain...
新聞Providence Health & Services partnered with HDT Biotech Corporation on Jun 8th '26.To address this, Providence Swedish forged a collaboration with Seattle-based HDT Bio that activates and expands T-cell function in the tumor microenvironment.
